Tomonori Oura

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Combination Therapy

Loop Mediated Isothermal Amplification

Coronary Artery

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

Journal of diabetes investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Kazuya Fujihara, Yasuhiro Matsubayashi, Masaru Kitazawa, Takaaki Sato, Masakazu Takeuchi, Tomonori Oura, Hirohito Sone
Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J-mono and J-combo studies. Diabetes, obesity & metabolism (2024)
Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Hitoshi Ishii, Tomonori Oura, Masakazu Takeuchi
Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Takeshi Osonoi, Tomonori Oura, Tetsuaki Hirase
Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes: A subgroup analysis of the SURPASS J-mono study. Diabetes, obesity & metabolism (2023)
Daisuke Yabe, Dan Kawamori, Yusuke Seino, Tomonori Oura, Masakazu Takeuchi
Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy). Diabetes, obesity & metabolism (2022)
Kenichi Furihata, Hanaka Mimura, Shweta Urva, Tomonori Oura, Shweta Urva, Takeshi Imaoka
A phase 1 multiple-ascending dose study of tirzepatide in Japanese participants with type 2 diabetes. Diabetes, obesity & metabolism (2021)
Masanari Shiramoto, Risa Nasu, Tomonori Oura, Makoto Imori, Kenji Ohwaki
Ultra-Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog® in Japanese patients with type 1 diabetes. Journal of diabetes investigation 11 (3) (2020)
Yukiko Onishi, Hitoshi Ishii, Tomonori Oura, Masakazu Takeuchi
Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (3) (2020)